A de novo loss‐of‐function DYNC1H1 mutation in a patient with parkinsonian features and a favourable response to levodopa
暂无分享,去创建一个
R. Płoski | M. Rydzanicz | J. Kosińska | M. Laure-Kamionowska | E. Pronicka | K. Szymanska | E. Ciara | D. Piekutowska-Abramczuk | K. Szczałuba | A. Walczak | P. Gasperowicz | A. Biernacka | K. Czerska | A. Jacoszek
[1] G. Ravenscroft,et al. Expanding the phenotypic spectrum associated with mutations of DYNC1H1 , 2017, Neuromuscular Disorders.
[2] S. Klebe,et al. Mutation screen reveals novel variants and expands the phenotypes associated with DYNC1H1 , 2015, Journal of Neurology.
[3] D. Lev,et al. Copy number variations in cryptogenic cerebral palsy , 2015, Neurology.
[4] M. Farrer,et al. DCTN1 mutations in Perry syndrome , 2009, Nature Genetics.
[5] R. Vallee,et al. Dynein: An ancient motor protein involved in multiple modes of transport. , 2004, Journal of neurobiology.